EAM
GH icon

Eventide Asset Management’s Guardant Health GH Stock Holding History

Eventide Asset Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218M Sell
2,362,379
-148,712
-6% -$14.9M 3.61% 1
2025
Q4 		$256M Sell
2,511,091
-810,247
-24% -$72.5M 4.01% 1
2025
Q3 		$208M Sell
3,321,338
-137,625
-4% -$7.49M 3.41% 1
2025
Q2 		$180M Sell
3,458,963
-107,775
-3% -$4.81M 3.15% 2
2025
Q1 		$152M Sell
3,566,738
-241,199
-6% -$10.4M 3.03% 2
2024
Q4 		$116M Sell
3,807,937
-29,363
-0.8% -$826K 2.12% 4
2024
Q3 		$88M Buy
3,837,300
+76,762
+2% +$2.17M 1.52% 14
2024
Q2 		$109M Sell
3,760,538
-418,894
-10% -$9.75M 1.86% 11
2024
Q1 		$86.2M Buy
4,179,432
+291,286
+7% +$6.24M 1.35% 21
2023
Q4 		$105M Buy
3,888,146
+298,616
+8% +$7.83M 1.72% 13
2023
Q3 		$106M Sell
3,589,530
-419,072
-10% -$14.7M 1.91% 12
2023
Q2 		$144M Buy
4,008,602
+2,133,582
+114% +$61.3M 2.43% 7
2023
Q1 		$44M Buy
1,875,020
+194,020
+12% +$5.54M 0.81% 43
2022
Q4 		$45.7M Hold
1,681,000
– – 0.9% 39
2022
Q3 		$90.5M Hold
1,681,000
– – 1.78% 19
2022
Q2 		$67.8M Buy
1,681,000
+368,100
+28% +$18.2M 1.45% 22
2022
Q1 		$87M Buy
1,312,900
+426,800
+48% +$29.2M 1.36% 29
2021
Q4 		$88.6M Buy
886,100
+708,100
+398% +$73.2M 1.13% 32
2021
Q3 		$22.3M Buy
+178,000
New +$21.1M 0.29% 90

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Eventide Asset Management's GH Position: Q1 2026 in Review

Eventide Asset Management reduced its Guardant Health (GH) stake by 5.9% in Q1 2026, selling an estimated $14.9M and leaving 2,362,379 shares worth $218M. The position accounts for 3.61% of the portfolio, ranked #1.

Eventide Asset Management first reported a position in GH in Q3 2021 and has held it in 19 quarters since. The position peaked at $256M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Eventide Asset Management held 2,362,379 shares of Guardant Health worth $218M as of Q1 2026.
  • Eventide Asset Management sold 148,712 Guardant Health shares in Q1 2026, an estimated $14.9M.
  • Guardant Health made up 3.61% of Eventide Asset Management's portfolio in Q1 2026, its #1 holding.
  • Eventide Asset Management first reported a position in Guardant Health in Q3 2021 and has held it in 19 quarters since.
  • Eventide Asset Management's Guardant Health position peaked at $256M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Eventide Asset Management's 13F filing for Q1 2026, filed 15 May 2026.